Compounds and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation

A technology of tumor cell proliferation and pharmaceutical composition, applied in the field of compounds

Inactive Publication Date: 2013-08-21
CHINA MEDICAL UNIVERSITY(TW)
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The current breast cancer treatment drugs have different side effects. When using them, the patient's own condition and medical history should be considered to achieve a better therapeutic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation
  • Compounds and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation
  • Compounds and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0053] Experimental example 1: Compound (I) can affect the survival rate of cancer cells in different tissues

[0054] The compound (I) of the embodiment of the present invention has the ability to kill various tumor cells. The median lethal dose (IC) of compound (I) to different cells 50 ) Refer to Table 1 below.

[0055] Table 1. Analysis of the effect of compound (I) on the activity of cancer cells in different tissues

[0056] cell type

[0057] From the results in Table 1, it can be seen that compound (I) has the most significant inhibitory effect on the development of breast cancer cells, and its IC 50 is 7.51 μM. Therefore, breast cancer cells will be taken as an example to analyze the effect of compound (I) on the growth of breast cancer cells.

experiment example 2-1

[0058] Experimental Example 2-1: Compound (I) inhibits the survival rate of breast cancer cells

[0059] The cells used in the experiment are human breast cell MCF-10A, human breast cancer cell MCF-7 and MDA-MB-231. MCF-7 is an estrogen receptor alpha (ERα) positive (ERα(+)) breast cancer cell line; MDA-MB-231 cell line is an estrogen receptor negative (ERα(-)) breast cancer cell line cell line.

[0060] Breast cancer cells (MDA-MB-231, MCF-7) were purchased from the Bioresource Collection and Research Center (BCRC), and cultured in DMEM containing 10% fetal bovine serum (FBS). in liquid culture medium. Human mammary gland cells MCF-10A were cultured in DMEM medium (fetal bovine serum-DMEM F12 / insulin / cortisol / epidermal growth factor) containing 5% fetal bovine serum (FBS). The incubator is maintained at 5% CO 2 , 37 ℃ constant temperature. When the cells were cultured to a certain number, the culture medium was removed by centrifugation at 900 revolutions (rpm) for 10 mi...

experiment example 1-2

[0066] Experimental Example 1-2: Compound (I) inhibits the formation of cell colonies of tumor cells

[0067] In order to understand the effect of compound (I) on the colony formation of breast cancer cell MDA-MB-231, it was observed by colony formation assay.

[0068] Figure 1B Part (a) of the cell is attached to the cell matrix, reacted with different concentrations of compound (I) for 24 hours, and then replaced with fresh 10% FBS cell culture medium, and cultured for 5 days. Colony growth; Figure 1B Part (b) is the value obtained after scanning the cell colony shown in part (a) on the computer and dissolving the colony with 70% alcohol, and measuring the absorbance at 540nm.

[0069] Figure 1B The results of part (a) show that compound (I) has a significant inhibition of the colony formation of breast cancer cells; the results of part (b) can be clearly seen that the number of breast cancer cell colonies formed in the experiment is related to the dose of compound (I) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Compounds of following general formula (I) and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation are disclosed. In formula (I), n is an integer from 0 to 9. The cell proliferation of breast tumor, ovarian tumor, skin tumor or liver tumor is inhibited by the compounds of the formula (I).

Description

technical field [0001] The present invention relates to a compound, in particular to a compound for inhibiting tumor cell proliferation in mammals and a pharmaceutical composition thereof. Background technique [0002] According to statistics, 250,000 people die of breast cancer every year in the world. From 1990 to 1991, the number of cancer deaths in Taiwan increased to 32,993, an increase of 3.83% in one year, accounting for 26.05% of the total mortality. Breast cancer is one of the top 10 cancers leading to death among women in Taiwan. It is gradually increasing, and the age of onset is younger than that in Europe and the United States. Every year, nearly 1,200 women die from breast cancer, which poses a serious threat to women's health. The occurrence of cancer is closely related to genes and acquired environment, especially closely related to diet. [0003] Breast cancer treatment methods include surgery, radiotherapy, chemotherapy, endocrine therapy, immunotherapy, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C50/28A61K31/122A61P15/14A61P15/00A61P17/00A61P1/16A61P35/00A61P35/04
CPCA61K36/07A61K31/122A61P1/16A61P15/00A61P15/14A61P17/00A61P35/00A61P35/04
Inventor 许游章杨新玲
Owner CHINA MEDICAL UNIVERSITY(TW)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap